×

Biocompatible poly-beta-1-4-N-acetylglucosamine

  • US 20040087015A1
  • Filed: 07/11/2003
  • Published: 05/06/2004
  • Est. Priority Date: 12/01/1993
  • Status: Active Grant
First Claim
Patent Images

1. A method for immunoisolation of a cell comprising:

  • coating a cell/poly-β

    -1→

    4-N-acetylglucosamine species, said cell/poly-β

    -1→

    4-N-acetylglucosamine species comprising a poly-β

    -1→

    4-N-acetylglucosamine species comprising about 4,000 to about 150,000 N-acetylglucosamine monosaccharides covalently attached in a β

    -1→

    4 conformation, free of protein, substantially free of other organic contaminants, substantially free of inorganic contaminants, and having a molecular weight of about 800,000 daltons to about 30 million daltons within with at least one cell is encapsulated, with a coating having a polyelectrolyte charge opposite to the charge of the cell/poly-β

    -1→

    4-N-acetylglucosamine species, so that the cell within the cell/poly-β

    -1→

    4-N-acetylglucosamine species is immunoisolated.

View all claims
  • 0 Assignments
Timeline View
Assignment View
    ×
    ×